Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma

Overview of attention for article published in Annals of Oncology, June 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

blogs: 1 blog

twitter: 3 X users

Readers on

mendeley: 43 Mendeley

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 52,657 followers.

https://t.co/Gfeo1bBqgb

RT @Annals_Oncology: New article in press: Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant ch…

https://t.co/xCnCGmWnKS https://t.co/0d7Vglss2t

New article in press: Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma https://t.co/xCnCGmWnKS

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.